Press Release: HIV Is Not a Crime IV Postponed to 2021
Mark your Calendar May 22-25, 2021
HIV JUSTICE WORLDWIDE STEERING COMMITTEE STATEMENT ON COVID-19 CRIMINALIZATION
Network Empowerment
ADVANCING HIV JUSTICE 3: Now Available in 4 languages!!
HIV Justice Worldwide
Is HIV stigma worse than ever?
Pennsylvania HIV Justice Network
Sero News
Press Release: Masking Fear & Discrimination/SERO Website
New Short Film Release
HIV Criminalization Activists Take Over the Stage @AIDS2015 Conference
AIDS2015 Durban South Africa
Personals and Networking
Sero on Twitter
Sero on Pinterest
Sero on Facebook
Dear Friends,
We have been watching the news, listening to the medical community and in touch with the Ohio State University. We have reluctantly, but unanimously, decided for the safety of our staff, advocates, and community members that we must postpone HIV is Not a Crime IV National Training Academy until 2021.
We have secured May 22 - 25, 2021 at The Ohio State University, please mark your calendars now.
HINAC4 Questions
I received a scholarship, what do I do?
Everyone who received a scholarship for HINAC4 will be given first priority for HINAC4 in 2021. We will send out an email closer to the time of the training academy to ensure scholarship awardees are still able to attend the 2021 dates.
I have registered for the Training Academy or I have paid my $75 discounted registration fee, what can I do?
Eventbrite offers 2 options:
For a refund, please contact Cindy Stine, at cindy.stine@seroproject.com, you can do it on Eventbrite, but it is easiest for Cindy to walk you through it.
If you do not want a refund, you can leave your registration and discounted registration fee in Eventbrite and it will be applied for HINAC4 2021.
My abstract was selected for HINAC4, what happens next?
We appreciate you sharing your expertise and time, similarly to the scholarship awardees, all abstracts submitted for HINAC4 will be given first priority in 2021. We will contact presenters closer to the Training Academy to ensure you are still willing and able to attend and present.
Will there be a virtual Training Academy?
The Program Work group will be discussing virtual sessions leading up to HINAC4 2021 and provide recommendations to the Executive Committee the best options moving forward. An announcement will be shared by all partner organizations after this decision is made.
On behalf of the Sero Project, Positive Women’s Network-USA, Positively Trans, THRIVE SS, and the US PLHIV Caucus, thank you all for your support as we move forward through this crisis. We will have a huge celebration in 2021 and look forward to seeing you at HINAC4.
If you have any questions or concerns, please contact Tami Haught, HINAC4 Director at tami.haught@seroproject.com. We will continue to provide updates throughout the process.
Sincerely,
Larry L. Scott-Walker, Executive Director,
THRIVE SS
www.thrivess.org/
Naina Khanna, Executive Director Positive Women’s Network - USA
www.pwn-usa.org/
Ronald Johnson, Chair
US PLHIV Caucus
www.hivcaucus.org/
Sean Strub, Executive Director
Sero Project
www.seroproject.com
Sophia Kass Martincus, Program Coordinator
Positively Trans
transgenderlawcenter.org/programs/positively-trans
THRIVE SS, Positive Women's Network - USA, U.S. PLHIV Caucus, Transgender Law Center
Registration Update
In order to make AIDSWatch 2020 as accessible as possible, the AIDSWatch organizing partners are now able to offer FREE registrations for AIDSWatch’s virtual advocacy materials.
All attendees who have already registered – as you all have – are receiving access to AIDSWatch 2020’s virtual advocacy materials, an AIDSWatch t-shirt mailed to your address, and a 50% discount on AIDSWatch 2021 registration. There is now also an option for Free Registration, including only access to AIDSWatch 2020’s virtual advocacy materials. Please visit our registration page for more info, and please share this update with your networks who might not have been able to join the AIDSWatch community!
Please do not hesitate to reach out with any questions or concerns to AIDSWatch@aidsunited.org. We look forward to being with you all, and sincerely appreciate your participation in the first ever virtual AIDSWatch!
-AIDS United, The Treatment Access Expansion Project, and The U.S. People Living with HIV Caucus
Please use Discount Code: AW2020Virtual when registering.
mm.swoogo.com/AIDSWatch2020
mm.swoogo.com
Waheedah Shabazz-ElThe Reunion Project
Admin · 2 hrs ·
The Reunion Project will host its 2nd COVID-19 webinar centering PLHIV tomorrow - Tuesday March 24th at 6:00p0m EST. 3:00pm PST:
Registration link: docs.google.com/forms/d/e/1FAIpQLSfonQJIT8ZJoU9GeiQm9EfQJ5K-t8_cfaKZwXcSb_tHoTkE-g/viewform?usp=s...
Zoom meeting link: zoom.us/w/465540346?tk=1ZQMx_ETYSeZ6Fj5RiffO4ZlVeHGh5xlrnPHoUozZPo.DQEAAAAAG7-U-hZrN0hNSkNwSVNVS0...
HIVMA released today a document on COVID-19 Special Considerations for People with HIV www.hivma.org/globalassets/covid-19-special-considerations_v5.pdf
IDSA COVID-19 Resource Center -- a compilation of COVID-related policies and protocols as well as coverage and payment-related information and will be updated as resources and new information becomes available.
www.idsociety.org/public-health/COVID-19-Resource-Center/
hivma.org
The SERO ProjectSero Project and The Cranky Queer are hosting a Covid 19 update this afternoon at 3 pm with Dr. Doug Manion and an introduction from JD Davids (The Cranky Queer). This will include the most up-to-date data and provide an opportunity for questions from those on the webinar. See flyer attached and feel free to share with your networks.
Register in advance for this meeting:
zoom.us/meeting/register/upAkcOCrrTsp5FHNnPwR3hWn2nxqRJ-I2A
About Dr. Doug Manion
Dr. Doug Manion is Board Certified in Internal Medicine and completed his Fellowship in Infectious Diseases in Ottawa, Canada. He received a clinical and bench research fellowship at Massachusetts General Hospital and Harvard Medical School. He has over 20 years of experience in drug development, including serving as Senior Vice President, Head of Specialty Development and Head of Japan and China R&D at Bristol-Myers Squib and other leadership roles at BMS overseeing various therapeutic areas, including virology, immunoscience, neurology, cardiology, metabolic diseases, genetically-defined diseases and fibrosis. Previous to BMS, he was Vice President of Clinical Development and Medical Affairs for HIV/AIDS at GlaxoSmithKline. He started his career at DuPont Pharmaceuticals. He serves on the Board of Directors of Celleron Therapeutics and is CEO and Chairman of Kleo Pharmaceuticals.
About JD Davids and The Cranky Queer
I'm writing The Cranky Queer Guide to Chronic Illness: Stories and Strategies for Sick Times. Here's why:
Queer and trans people have always had to find new paths.
We can and must become “illders”: wise elders of any age who turn the demands of living with chronic conditions into opportunities for self-knowledge, growth and connection.
Subscribe to @TheCrankyQueer today.
#CrankyQueer
CrankyQueer.com
Newsletter: bit.ly/crankyqueer
Facebook: CrankyQueer
Twitter: @TheCrankyQueer
Instagram: TheCrankyQueer
Sero on Instagram
